2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HER2+ MBC: Comparing Efficacy of HER2 Kinase Inhibitors vs. Antibody Drug Conjugates vs. Immunomodulatory Agents

570 views
July 13, 2020
Comments 0
Login to view comments. Click here to Login